(52 days)
The Wagner Cone Prosthesis is intended for prosthetic replacement of the proximal portion of the femur in total hip arthroplasty. This device is intended for cementless application where primary fixation occurs predominantly in the distal region. Specific diagnostic indications for use of the Wagner Cone Prosthesis are:
- patient conditions of noninflammatory degenerative joint disease (NIDJD), e.g., avascular necrosis, osteoarthritis, and inflammatory joint disease (IJD), e.g., rheumatoid arthritis;
- those patients with failed previous surgery where pain, deformity, or dysfunction persists;
- revision of previously failed hip arthroplasty.
This stem is a titanium-aluminum-niobium alloy conical configuration with a taper. The design features a circular cross-section with eight equally spaced conical longitudinal flutes down the long axis of the stem for rotational stability. The stem's core diameter tapers gradually from the proximal end to the distal end.
The provided document is a 510(k) premarket notification for the Wagner Cone Prosthesis, a hip joint implant. It describes the device, its intended use, and its substantial equivalence to predicate devices. However, this document does not contain information regarding acceptance criteria, device performance metrics, or study results in the context of AI/ML device evaluation.
The 510(k) approval process for orthopedic implants typically relies on demonstrating substantial equivalence to a legally marketed predicate device through:
- Design comparisons: Showing the new device has similar materials, design features, and operating principles to approved predicate devices.
- Functional analyses: Testing the physical and mechanical properties of the device (e.g., strength, fatigue life, wear resistance) to show it performs comparably to or better than predicate devices. These tests are usually conducted in a laboratory setting according to recognized standards (e.g., ISO, ASTM).
- Performance tests: These refer to mechanical and material tests, not clinical performance in the sense of a diagnostic or predictive AI/ML model.
Therefore, I cannot fulfill your request for information regarding acceptance criteria and study details related to AI/ML device performance from this document. The questions you've asked (sample sizes, ground truth establishment, expert adjudication, MRMC studies, standalone performance) are highly relevant to AI/ML device submissions but are not addressed in this type of traditional medical device 510(k) summary.
§ 888.3353 Hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis.
(a)
Identification. A hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis is a device intended to be implanted to replace a hip joint. This device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. The two-part femoral component consists of a femoral stem made of alloys to be fixed in the intramedullary canal of the femur by impaction with or without use of bone cement. The proximal end of the femoral stem is tapered with a surface that ensures positive locking with the spherical ceramic (aluminium oxide, A12 03 ) head of the femoral component. The acetabular component is made of ultra-high molecular weight polyethylene or ultra-high molecular weight polyethylene reinforced with nonporous metal alloys, and used with or without bone cement.(b)
Classification. Class II.